mvt-5873
Showing 1 - 5 of 5
Pancreatic Carcinoma, Tumors That Express CA 19-9 Trial in Scottsdale, New York (MVT-1075, MVT-5873)
Suspended
- Pancreatic Carcinoma
- Tumors That Express CA 19-9
- MVT-1075
- MVT-5873
-
Scottsdale, Arizona
- +1 more
Aug 23, 2022
Colon Cancer, Pancreatic Cancer, Cholangiocarcinoma Trial run by the National Cancer Institute (NCI) (MVT-5873, pancreatectomy
Completed
- Colon Cancer
- +4 more
- MVT-5873
- pancreatectomy or hepatectomy
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jun 30, 2022
Pancreatic Cancer Trial in United States (MVT-5873, modified FOLFIRINOX (mFOLFIRINOX))
Recruiting
- Pancreatic Cancer
- MVT-5873
- modified FOLFIRINOX (mFOLFIRINOX)
-
Scottsdale, Arizona
- +3 more
Aug 17, 2022
Pancreatic Carcinoma, Tumors That Express CA19-9 Trial in New York (MVT-2163, MVT-5873)
Terminated
- Pancreatic Carcinoma
- Tumors That Express CA19-9
- MVT-2163
- MVT-5873
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Aug 26, 2021
Pancreatic Cancer, Tumors That Express CA19-9 Trial in United States (MVT-2163, MVT-5873)
Recruiting
- Pancreatic Cancer
- Tumors That Express CA19-9
- MVT-2163
- MVT-5873
-
Basking Ridge, New Jersey
- +6 more
May 3, 2022